Nádasdi Á - Search Results

1

The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus.

Firneisz G, Rosta K, Al-Aissa Z, Hadarits O, Harreiter J, Nádasdi Á, Bancher-Todesca D, Németh L, Igaz P, Rigó J Jr, Sziller I, Kautzky-Willer A, Somogyi A. Firneisz G, et al. Among authors: nadasdi a. Int J Mol Sci. 2018 Nov 23;19(12):3734. doi: 10.3390/ijms19123734. Int J Mol Sci. 2018. PMID: 30477160 Free PMC article.

2

Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development.

Rosta K, Al-Aissa Z, Hadarits O, Harreiter J, Nádasdi Á, Kelemen F, Bancher-Todesca D, Komlósi Z, Németh L, Rigó J Jr, Sziller I, Somogyi A, Kautzky-Willer A, Firneisz G. Rosta K, et al. Among authors: nadasdi a. PLoS One. 2017 Jan 10;12(1):e0169781. doi: 10.1371/journal.pone.0169781. eCollection 2017. PLoS One. 2017. PMID: 28072873 Free PMC article.

3

[Non-alcoholic fatty liver disease - a summary and update based on the EASL-EASD-EASO Clinical Practice Guidelines of 2016].

Nádasdi Á, Somogyi A, Igaz P, Firneisz G. Nádasdi Á, et al. Orv Hetil. 2018 Nov;159(45):1815-1830. doi: 10.1556/650.2018.31231. Orv Hetil. 2018. PMID: 30415572 Review. Hungarian.

4

Comments on: A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus.

Rosta K, Harreiter J, Nádasdi Á, Németh L, Kautzky-Willer A, Somogyi A, Firneisz G. Rosta K, et al. Among authors: nadasdi a. Biosci Rep. 2020 Feb 28;40(2):BSR20194316. doi: 10.1042/BSR20194316. Biosci Rep. 2020. PMID: 32022227 Free PMC article.

5

Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus.

Firneisz G, Rosta K, Rigó J, Nádasdi Á, Harreiter J, Kautzky-Willer A, Somogyi A. Firneisz G, et al. Among authors: nadasdi a. Front Genet. 2020 Apr 21;11:332. doi: 10.3389/fgene.2020.00332. eCollection 2020. Front Genet. 2020. PMID: 32373162 Free PMC article. No abstract available.

6

Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients.

Nádasdi Á, Sinkovits G, Bobek I, Lakatos B, Förhécz Z, Prohászka ZZ, Réti M, Arató M, Cseh G, Masszi T, Merkely B, Ferdinandy P, Vályi-Nagy I, Prohászka Z, Firneisz G. Nádasdi Á, et al. Biomark Med. 2022 Apr;16(5):317-330. doi: 10.2217/bmm-2021-0717. Epub 2022 Feb 23. Biomark Med. 2022. PMID: 35195023 Free PMC article.

7

Combined effect of pancreatic lipid content and gene variants (TCF7L2, WFS1 and 11BHSD1) on B-cell function in Middle Aged Women in a Post Hoc Analysis.

Nádasdi Á, Gál V, Masszi T, Patócs A, Igaz P, Somogyi A, Firneisz G. Nádasdi Á, et al. Diabetol Metab Syndr. 2022 Jul 27;14(1):106. doi: 10.1186/s13098-022-00876-z. Diabetol Metab Syndr. 2022. PMID: 35897035 Free PMC article.

8

PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content.

Nádasdi Á, Gál V, Masszi T, Somogyi A, Firneisz G. Nádasdi Á, et al. Cardiovasc Diabetol. 2023 Mar 21;22(1):64. doi: 10.1186/s12933-023-01792-w. Cardiovasc Diabetol. 2023. PMID: 36944955 Free PMC article.

9

Association between cardiovascular autonomic neuropathy and multimetabolic syndrome in a special cohort of women with prior gestational diabetes mellitus.

Kerényi Z, Stella P, Nádasdi A, Tabák AG, Tamás G. Kerényi Z, et al. Among authors: nadasdi a. Diabet Med. 1999 Sep;16(9):794-5. Diabet Med. 1999. PMID: 10510961 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters